Advisor Shares Investments LLC Cardiol Therapeutics Inc. Transaction History
Advisor Shares Investments LLC
- $538 Million
- Q3 2025
A detailed history of Advisor Shares Investments LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Shares Investments LLC holds 557,388 shares of CRDL stock, worth $568,535. This represents 0.11% of its overall portfolio holdings.
Number of Shares
557,388
Previous 857,388
34.99%
Holding current value
$568,535
Previous $1.17 Million
50.34%
% of portfolio
0.11%
Previous 0.22%
Shares
18 transactions
Others Institutions Holding CRDL
# of Institutions
52Shares Held
7.39MCall Options Held
25KPut Options Held
0-
Tejara Capital LTD London, X02.63MShares$2.68 Million1.47% of portfolio
-
Bank Of America Corp Charlotte, NC551KShares$562,0740.0% of portfolio
-
Marshall Wace, LLP London, X0544KShares$555,2030.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il463KShares$472,7310.0% of portfolio
-
Goldman Sachs Group Inc New York, NY322KShares$328,2360.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $63.2M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...